Graybill JR and Bocanegra R |
Treatment alternatives for Mycobacterium kansasii. |
2001 |
J. Antimicrob. Chemother. |
pmid:11266413
|
Ferwerda A et al. |
Efficacy, safety and tolerability of 3 day azithromycin versus 10 day co-amoxiclav in the treatment of children with acute lower respiratory tract infections. |
2001 |
J. Antimicrob. Chemother. |
pmid:11266417
|
Butler T et al. |
In vitro effects of azithromycin on Salmonella typhi: early inhibition by concentrations less than the MIC and reduction of MIC by alkaline pH and small inocula. |
2001 |
J. Antimicrob. Chemother. |
pmid:11266420
|
St Clair EW et al. |
The effects of intravenous doxycycline therapy for rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. |
2001 |
Arthritis Rheum. |
pmid:11357896
|
Kaplan EL et al. |
Macrolide therapy of group A streptococcal pharyngitis: 10 days of macrolide therapy (clarithromycin) is more effective in streptococcal eradication than 5 days (azithromycin). |
2001 |
Clin. Infect. Dis. |
pmid:11360224
|
Nilius AM et al. |
Comparative in vitro activity of ABT-773, a novel antibacterial ketolide. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11408246
|
Vallejo C et al. |
Resolution of cyclosporine-induced gingival hyperplasia resistant to azithromycin by switching to tacrolimus. |
2001 |
Haematologica |
pmid:11146586
|
Schlegel L et al. |
In vitro activity of midecamycin diacetate, a 16-membered macrolide, against Streptococcus pyogenes isolated in France, 1995-1999. |
2001 |
Clin. Microbiol. Infect. |
pmid:11531981
|
Kurdowska A et al. |
The effect of azithromycin and clarithromycin on ex vivo interleukin-8 (IL-8) release from whole blood and IL-8 production by human alveolar macrophages. |
2001 |
J. Antimicrob. Chemother. |
pmid:11389120
|
Thompson C et al. |
A family cluster of Chlamydia trachomatis infection. |
2001 |
BMJ |
pmid:11408308
|
Jacobson GF et al. |
A randomized controlled trial comparing amoxicillin and azithromycin for the treatment of Chlamydia trachomatis in pregnancy. |
2001 |
Am. J. Obstet. Gynecol. |
pmid:11408852
|
Matsunaga T |
[Pharmacological and pharmacokinetic properties of azithromycin (Zithromac), a novel 15-membered ring macrolide antibacterial agent]. |
2001 |
Nippon Yakurigaku Zasshi |
pmid:11411344
|
Kain KC et al. |
Malaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens. |
2001 |
Clin. Infect. Dis. |
pmid:11418883
|
Tabbara KF |
Trachoma: a review. |
2001 |
J Chemother |
pmid:11434524
|
Lisby G et al. |
Bacteremia and meningitis caused by a macrolide-sensitive strain of Streptococcus pneumoniae during treatment with azithromycin. |
2001 |
Clin. Infect. Dis. |
pmid:11438918
|
Ishimatsu Y et al. |
[Effect of macrolide antibiotics on apoptosis induction]. |
2001 |
Jpn J Antibiot |
pmid:11439895
|
O'Farrell N |
Donovanosis: an update. |
2001 |
Int J STD AIDS |
pmid:11394976
|
Schmutz JL et al. |
[Skin eruptions due to azithromycin (Azadose-Zithromax) and infectious mononucleosis]. |
2001 |
Ann Dermatol Venereol |
pmid:11395665
|
Tyteca D et al. |
Azithromycin, a lysosomotropic antibiotic, impairs fluid-phase pinocytosis in cultured fibroblasts. |
2001 |
Eur. J. Cell Biol. |
pmid:11499789
|
Chokephaibulkit K et al. |
Intestinal parasitic infections among human immunodeficiency virus-infected and -uninfected children hospitalized with diarrhea in Bangkok, Thailand. |
2001 |
Southeast Asian J. Trop. Med. Public Health |
pmid:12041552
|
Solera J et al. |
Azithromycin and gentamicin therapy for the treatment of humans with brucellosis. |
2001 |
Clin. Infect. Dis. |
pmid:11170962
|
Gerber MA and Tanz RR |
New approaches to the treatment of group A streptococcal pharyngitis. |
2001 |
Curr. Opin. Pediatr. |
pmid:11176244
|
Conrad DA |
Treatment of cat-scratch disease. |
2001 |
Curr. Opin. Pediatr. |
pmid:11176245
|
Mamikoglu B and Mamikoglu O |
Irreversible sensorineural hearing loss as a result of azithromycin ototoxicity. A case report. |
2001 |
Ann. Otol. Rhinol. Laryngol. |
pmid:11201801
|
Sahm DF et al. |
Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysis. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11257013
|
Lietman T and Fry A |
Can we eliminate trachoma? |
2001 |
Br J Ophthalmol |
pmid:11264123
|
Fuchs PC et al. |
Influence of variations in test methods on susceptibility of Haemophilus influenzae to ampicillin, azithromycin, clarithromycin, and telithromycin. |
2001 |
J. Clin. Microbiol. |
pmid:11136745
|
Citterio F et al. |
Azithromycin treatment of gingival hyperplasia in kidney transplant recipients is effective and safe. |
2001 |
Transplant. Proc. |
pmid:11377476
|
Solomon AW et al. |
Pilot study of the use of community volunteers to distribute azithromycin for trachoma control in Ghana. |
2001 |
Bull. World Health Organ. |
pmid:11217675
|
Simsir A et al. |
Rhodococcus equi and cytomegalovirus pneumonia in a renal transplant patient: diagnosis by fine-needle aspiration biopsy. |
2001 |
Diagn. Cytopathol. |
pmid:11169894
|
Nagai K et al. |
Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11600391
|
Cascaval RI and Lancaster DJ |
Hypersensitivity syndrome associated with azithromycin. |
2001 |
Am. J. Med. |
pmid:11247598
|
Amábile-Cuevas CF et al. |
Comparative in vitro activity of moxifloxacin by E-test against Streptococcus pyogenes. |
2001 |
Clin. Infect. Dis. |
pmid:11249826
|
De Diego JI et al. |
Comparison of amoxicillin and azithromycin in the prevention of recurrent acute otitis media. |
2001 |
Int. J. Pediatr. Otorhinolaryngol. |
pmid:11249979
|
Ioannidis JP et al. |
Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for upper respiratory tract infections. |
2001 |
J. Antimicrob. Chemother. |
pmid:11679557
|
Contopoulos-Ioannidis DG et al. |
Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for lower respiratory tract infections. |
2001 |
J. Antimicrob. Chemother. |
pmid:11679558
|
Laurent J et al. |
A randomized comparison of four omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11683693
|
Woolard S and Kenkel D |
Heading off antibiotic resistance. |
2001 |
Adv Nurse Pract |
pmid:12420432
|
Chahine C et al. |
Ultrashort regimen of lansoprazole-amoxicillin-azithromycin for eradicating Helicobacter pylori. |
2001 |
Am J Health Syst Pharm |
pmid:11596697
|
Weigl LB et al. |
[Confluent and reticulate papillomatosis. Successful therapy with azithromycin]. |
2001 |
Hautarzt |
pmid:11715390
|
Gray RH et al. |
Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda. |
2001 |
Am. J. Obstet. Gynecol. |
pmid:11717659
|
|
Intrauterine devices: antibiotic prophylaxis not necessary during insertion. |
2001 |
Prescrire Int |
pmid:11718174
|
Golledge CL and Riley TV |
The efficacy of an antibiotic protocol for community-acquired pneumonia. |
2001 |
Med. J. Aust. |
pmid:11700844
|
Toro C et al. |
[Prevalence of primary Helicobacter pylori resistance to eight antimicrobial agents in a hospital in Madrid]. |
2001 |
Rev Esp Quimioter |
pmid:11704771
|
Tajima T et al. |
[Discussions on PRSP and BLNAR]. |
2001 |
Jpn J Antibiot |
pmid:12638161
|
Samarendra P et al. |
QT prolongation associated with azithromycin/amiodarone combination. |
2001 |
Pacing Clin Electrophysiol |
pmid:11707055
|
Hand WL and Hand DL |
Characteristics and mechanisms of azithromycin accumulation and efflux in human polymorphonuclear leukocytes. |
2001 |
Int. J. Antimicrob. Agents |
pmid:11711255
|
Treadway G and Reisman A |
Tolerability of 3-day, once-daily azithromycin suspension versus standard treatments for community-acquired paediatric infectious diseases. |
2001 |
Int. J. Antimicrob. Agents |
pmid:11711256
|
Urbano F and Urbano P |
Azithromycin in healthy adults? |
2001 |
Clin. Microbiol. Infect. |
pmid:11531993
|
Miyazaki S et al. |
Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice. |
2001 |
J. Antimicrob. Chemother. |
pmid:11533011
|
Milkovic-Kraus S and Kanceljak-Macan B |
Occupational airborne allergic contact dermatitis from azithromycin. |
2001 |
Contact Derm. |
pmid:11553158
|
Gray GC and Ryan MA |
Azithromycin chemoprophylaxis. |
2001 |
J. Infect. Dis. |
pmid:11494171
|
Arellano-Rodrigo E et al. |
[Torsade de pointes and cardiorespiratory arrest induced by azithromycin in a patient with congenital long QT syndrome]. |
2001 |
Med Clin (Barc) |
pmid:11459586
|
Dillon JA et al. |
Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from three Caribbean countries: Trinidad, Guyana, and St. Vincent. |
2001 |
Sex Transm Dis |
pmid:11518867
|
Dillon JA et al. |
Reduced susceptibility to azithromycin and high percentages of penicillin and tetracycline resistance in Neisseria gonorrhoeae isolates from Manaus, Brazil, 1998. |
2001 |
Sex Transm Dis |
pmid:11518869
|
Damianov L et al. |
[Treatment of genital chlamydia infections with Sumamed]. |
2001 |
Akush Ginekol (Sofiia) |
pmid:11519320
|
Doern GV |
Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States. |
2001 |
Clin. Infect. Dis. |
pmid:11524718
|
Noedl H et al. |
Antimalarial activity of azithromycin, artemisinin and dihydroartemisinin in fresh isolates of Plasmodium falciparum in Thailand. |
2001 |
Acta Trop. |
pmid:11495642
|
Fraser-Hurt N et al. |
Efficacy of oral azithromycin versus topical tetracycline in mass treatment of endemic trachoma. |
2001 |
Bull. World Health Organ. |
pmid:11477966
|
Skerk V et al. |
Azithromycin and doxycycline in the treatment of female patients with acute urethral syndrome caused by Ureaplasma urealyticum: significance of duration of clinical symptoms. |
2001 |
Drugs Exp Clin Res |
pmid:11822223
|
|
[Antibiotics in respiratory tract infections. Enormous differences in compliance]. |
2001 |
MMW Fortschr Med |
pmid:11824169
|
|
[Chronic bronchitis. When to use antibiotics?]. |
2001 |
MMW Fortschr Med |
pmid:11824170
|
Samra Z et al. |
In vitro susceptibility of recent clinical isolates of Chlamydia trachomatis to macrolides and tetracyclines. |
2001 |
Diagn. Microbiol. Infect. Dis. |
pmid:11337185
|
Chodorowska M et al. |
[Susceptibility to macrolide antibiotics of Bordetella pertussis and Bordetella parapertussis strains isolated from whooping cough patients in 1968 and in 1997-99]. |
2001 |
Med Dosw Mikrobiol |
pmid:11757403
|
Jacks S et al. |
Pharmacokinetics of azithromycin and concentration in body fluids and bronchoalveolar cells in foals. |
2001 |
Am. J. Vet. Res. |
pmid:11763173
|
Bragina EY et al. |
Electron microscopic evidence of persistent chlamydial infection following treatment. |
2001 |
J Eur Acad Dermatol Venereol |
pmid:11763379
|
Swanston WH et al. |
Single dose (direct observed) azithromycin therapy for Neisseria gonorrhoeae and Chlamydia trachomatis in STD clinic attenders with genital discharge in Trinidad and Tobago. |
2001 |
West Indian Med J |
pmid:11769023
|
Mendes CM et al. |
In vitro susceptibility of gram-positive cocci isolated from skin and respiratory tract to azithromycin and twelve other antimicrobial agents. |
2001 |
Braz J Infect Dis |
pmid:11779453
|
Castor D et al. |
Antibiotic resistant N. gonorrhoeae in Trinidad and Tobago. |
2001 |
Cell. Mol. Biol. (Noisy-le-grand) |
pmid:11785665
|
van der Griend B et al. |
An uncommon cause of a destructive vulval lesion. |
2001 |
Aust N Z J Obstet Gynaecol |
pmid:11787928
|
Bain DL et al. |
Chlamydial genovar distribution after community wide antibiotic treatment. |
2001 |
J. Infect. Dis. |
pmid:11740734
|
Najib NM et al. |
Bioequivalence assessment of Azomycin (Julphar, UAE) as compared to Zithromax (Pfizer, USA)--two brands of azithromycin--in healthy human volunteers. |
2001 |
Biopharm Drug Dispos |
pmid:11745903
|
Skerk V et al. |
Azithromycin in the treatment of chronic prostatitis caused by Chlamydia trachomatis. |
2001 |
J Chemother |
pmid:11806631
|
Stiefelhagen P |
[Treatment refractory fever... und then also the kidneys fail]. |
2001 |
MMW Fortschr Med |
pmid:11808449
|
Andersen SE et al. |
[Failed azithromycin treatment of Chlamydia trachomatis infection]. |
2001 |
Ugeskr. Laeg. |
pmid:11810790
|
Zarantonelli L et al. |
Decreased susceptibility to azithromycin and erythromycin mediated by a novel mtr(R) promoter mutation in Neisseria gonorrhoeae. |
2001 |
J. Antimicrob. Chemother. |
pmid:11328778
|
Safak MA et al. |
A comparative study of azithromycin and pseudoephedrine hydrochloride for otitis media with effusion in children. |
2001 |
Acta Otolaryngol. |
pmid:11813896
|
Kays MB and Denys GA |
In vitro activity and pharmacodynamics of azithromycin and clarithromycin against Streptococcus pneumoniae based on serum and intrapulmonary pharmacokinetics. |
2001 |
Clin Ther |
pmid:11318076
|
Dinos GP et al. |
Insights into the mechanism of azithromycin interaction with an Escherichia coli functional ribosomal complex. |
2001 |
Mol. Pharmacol. |
pmid:11353804
|
Gupta S et al. |
Pharmacokinetic and safety profile of desloratadine and fexofenadine when coadministered with azithromycin: a randomized, placebo-controlled, parallel-group study. |
2001 |
Clin Ther |
pmid:11318079
|
Parsad D et al. |
Azithromycin monthly pulse vs daily doxycycline in the treatment of acne vulgaris. |
2001 |
J. Dermatol. |
pmid:11280457
|
Waring AL et al. |
Development of a genomics-based PCR assay for detection of Mycoplasma pneumoniae in a large outbreak in New York State. |
2001 |
J. Clin. Microbiol. |
pmid:11283060
|
Lechner A and Bruckner DA |
Oligella ureolytica in blood culture: contaminant or infection? |
2001 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:11305472
|
Nagata T et al. |
[Two cases successfully treated with long-term administration of low-dosage azithromycin]. |
2001 |
Jpn J Antibiot |
pmid:12575407
|
Dreses-Werringloer U et al. |
Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11600348
|
Littler WA |
Clindamycin suspension and endocarditis prophylaxis. |
2001 |
Br Dent J |
pmid:11352383
|
Ikegaya S et al. |
[Effect of azithromycin on cytokine production by THP-1 cells]. |
2001 |
Jpn J Antibiot |
pmid:12575425
|
Tateda K et al. |
Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11353657
|
Kato T et al. |
[Effect of azithromycin on cytokine production in human bronchial epithelial cell line, BEAS-2B]. |
2001 |
Jpn J Antibiot |
pmid:12575426
|
Pechère JC |
Azithromycin reduces the production of virulence factors in Pseudomonas aeruginosa by inhibiting quorum sensing. |
2001 |
Jpn J Antibiot |
pmid:12575427
|
Holm SO et al. |
Comparison of two azithromycin distribution strategies for controlling trachoma in Nepal. |
2001 |
Bull. World Health Organ. |
pmid:11285662
|
Tateda K et al. |
[MIC, sub-MIC of macrolide resistant bacteria--special reference to their quorum-sensing system]. |
2001 |
Jpn J Antibiot |
pmid:12575433
|
Frick KD et al. |
Cost-effectiveness of trachoma control measures: comparing targeted household treatment and mass treatment of children. |
2001 |
Bull. World Health Organ. |
pmid:11285663
|
Bailey R and Lietman T |
The SAFE strategy for the elimination of trachoma by 2020: will it work? |
2001 |
Bull. World Health Organ. |
pmid:11285668
|
Sorvillo F et al. |
Incidence and determinants of Pseudomonas aeruginosa infection among persons with HIV: association with hospital exposure. |
2001 |
Am J Infect Control |
pmid:11287873
|
Edelstein PH et al. |
In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11451675
|
Rubinstein E |
Comparative safety of the different macrolides. |
2001 |
Int. J. Antimicrob. Agents |
pmid:11574199
|
Skerk V et al. |
Duration of clinical symptoms in female patients with acute urethral syndrome caused by Chlamydia trachomatis treated with azithromycin or doxycycline. |
2001 |
J Chemother |
pmid:11330365
|
RodrÃguez Núñez A et al. |
[Chemoprophylaxis of meningococcal disease with azithromycin and ciprofloxacin]. |
2001 |
An. Esp. Pediatr. |
pmid:11333489
|
Grand A et al. |
[Subacute infectious endocarditis due to the agent of cat scratch fever: Bartonella henselae]. |
2001 |
Arch Mal Coeur Vaiss |
pmid:11265556
|